And today, the island continues to prove it has the workforce, infrastructure, and resilience that global pharma leaders rely on
Nausea on GLP-1 medications is driven by central and peripheral drug mechanisms, and no probiotic strain addresses that directly
The next generation of oral GLP-1s, such as Orforglipron and high-dose oral semaglutide, are showing weight loss results in trials that are much closer to those of their injectable counterparts
This physiological effect, shared with other drugs in the GLP-1 class, creates a plausible biological basis for reflux-type symptoms in some individuals
Blood backs up in your pulmonary veins because your heart can't keep up, letting fluid leak into your lungs
Vermont issued the first demand in May 2025 and a second in January 2026, seeking details on Kraft Heinzs research partnerships, marketing firms, and internal product records